Bio Med Sciences hosted a Private Hospitality Reception at the 42nd Annual American Burn Association Conference in Boston, MA on March 11, 2010. The event was held at Dillon's Restaurant &…
Bio Med Sciences, Inc. of Allentown, PA will launch a new cosmeceutical product next month. SeaAllureTM is an innovative, nighttime skin-firming patch clinically proven to reduce the appearance of facial…
Today Mark Dillon, founder of Bio Med Sciences, was presented with an award for “Distinguished Achievement” by Charles Edmonson, the President of Alfred University. Mark graduated from Alfred in 1987,…
Bio Med Sciences, Inc. has been awarded the Incubator Graduate Award from the Ben Franklin Technology Partners of Northeastern Pennsylvania for best demonstrating successful Ben Franklin Business incubation. According to…
Bio Med Sciences, Inc. has won $100,000 in research funds from the Life Sciences Greenhouse of Central PA (LSGPA) to pursue “Improved Topical Treatments for Hypertrophic Scars and Keloids”. The…
Bio Med Sciences, Inc. announced today that Pfizer, Inc. of New York, NY has recently introduced Neosporin® Scar SolutionTM based on Bio Med’s proprietary Silon® technology. Scar SolutionTM is intended…
Bio Med Sciences Offers Innovation Excellence Worldwide Pittsburgh, PA - Bio Med Sciences is pleased to announce that it has received the Governor's Export Excellence Award for the year 2001…
Silon-TSR® demonstrated more comfort and better durability as compared to a conventional biosynthetic dressings for skin sloughing syndrome management. Additionally, there were significant differences resulting in less nursing time required per dressing; decreased overall pain assessment and decreased costs using the Silon® material.
Awesome Customer Service! I ordered yesterday; order received today! Can’t wait to use it! Thank You!
The meshed autograft site provided an excellent basis for comparison – the Silon-TSR® allowed the interstices of the graft to close more rapidly…allowed increased moisture vapor transmission…additionally, the fresh epithelium was not disrupted when the dressing was removed.
The Dual-Dress 50® dressing maintains a high absorbency (8.2 grams water per gram of foam) while demonstrating minimal changes in swelling or expansion (<20%) – further providing consistent graft contact. We now use this dressing on essentially all cases where mechanical protection and shielding of the wound is required and have found this to be significantly useful for difficult burn management.
Oleeva® Fabric had the ideal combination of elasticity and strength to overcome mild eyelid retraction and prevent further contracture. Furthermore, the silicone lining safely adhered to the skin, softening the scar and providing gentle compression – both key tenants of effective scar management.
Cost effective treatment – the durability of Silon-STS® allows the silicone layer to last the life of the splint, far exceeding the use of other individual silicone gel sheets and splint materials for this scar application. This material provides another useful and effective treatment option for the burn therapist to employ in the management of neck and chin scar hypertrophy.
In the Spring of this year I had surgery, used your scar shape product for 12wks, very happy with the results. You have a great product and excellent customer service, all at a reasonable price. You DO have a superior product. In my work I am frequently asked for referrals, including scar management post-plastic surgery, and I am happy to recommend your scar shapes.
Use of Silon-LTS® provided a cost effective scar device that has reduced the contracture and hastened the need for contracture release. Additionally, the combined use of pressure and silicone in this material helps to enhance compliance in the pediatric population and facilitate cosmeis with only limited use.
The Silon-TSR® dressing application decreases immediate postoperative morbidity and significantly reduces the severity and duration of erythema, and decreases the duration of swelling and crusting after laser resurfacing procedures.
Advantages of the Silon-TSR® include nonadherence to the wound, no tendency to reinjure the wound with removal, the accumulation of growth factors at the wound surface and oxygen exchange. Patients prefer the dressing due to increased mobility, less accumulation of exudates at the base of the dressing and no adherence to the wound…patients rated cosmetic results better at 6 months as compared to our SOC dressings.
